Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Nanoink appoints James M. Hussey CEO

NanoInk, Inc. announced today the appointment of James M. Hussey, 48, as its Chief Executive Officer, as well as a member of its Board of Directors.

Nanoink appoints James M. Hussey CEO

SKOKIE, IL | Posted on January 22nd, 2008

Mr. Hussey joins NanoInk from Ovation Pharmaceuticals, Inc., a leading biopharmaceutical company where he served on the senior management team. Mr. Hussey will be a member of the external Advisory Board of Ovation and remain involved with the company. Mr. Hussey is also an angel investor and has been involved with or founded several early stage biotechnology companies including Silamed Pharmaceuticals, ProCor Pharmaceuticals and Barbeau Pharmaceuticals.

Prior to joining Ovation Pharmaceuticals, Mr. Hussey served as president and chief executive officer of NeoPharm, Inc., a biotechnology company specializing in the research, development and marketing of cancer drugs. Mr. Hussey also served as a director of Option Care, a local pharmacy infusion company, from 1999 until 2004.

Mr. Hussey began his career at Bristol-Myers Squibb in marketing, sales and new business development before being appointed to general manager in 1994. In 1995, he founded and served as chief executive officer of Physicians Quality Care, a physician management services organization in Oak Brook, Ill. which was sold in 1998.

Mr. Hussey received a B.S. degree in Pharmacy from Butler University and a Master of Business Administration degree from University of Illinois at Chicago. He currently serves on the Board of the Illinois Biotechnology Organization.

"We are delighted to have Jim lead the NanoInk team," said Mark Slezak, Chairman of the Company's Board of Directors. "He brings to us over two decades of executive management, product development and marketing leadership at both small and large pharmaceutical companies. His expertise and leadership will help drive NanoInk's growth in the future."

In accepting his appointment, Mr. Hussey said, "I am extremely excited about the opportunities of both Brand Protection and Dip Pen Nanolithography (DPN). NanoInk is a high quality organization with an extremely promising future."


About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

David Gutierrez
Dresner Corporate Services

Joshua Taustein
Dresner Corporate Services

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014


Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

A molecular approach to solar power: Switchable material could harness the power of the sun ó even when itís not shining April 15th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014

Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014

Global 450 consortium announces new general manager of internal operations: TSMCís Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE